Group 1 - The company held its seventh meeting of the fourth Supervisory Board on July 2, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2]. - The Supervisory Board approved the adjustment of the grant price for the 2024 restricted stock incentive plan from 22.30 CNY per share to 21.91 CNY per share [1][2]. - The Supervisory Board also approved the grant of reserved restricted stock to eligible incentive objects, confirming that all conditions for the incentive plan have been met [2][3]. Group 2 - The voting results showed unanimous support, with 100% of supervisors in favor of the proposals, indicating strong internal consensus [2][3]. - The reserved grant date for the incentive plan was set for July 2, 2025, aligning with the approved adjustments [3].
昊帆生物: 第四届监事会第七次会议决议公告